Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_assertion type Assertion NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_head.
- NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_assertion description "[The current results suggest absence of ERBB-2 overexpression in uterine leiomyosarcoma, uterine adenosarcoma, and endometrial stromal sarcoma, whereas the ERBB-2 gene might have a biologic role in uterine carcinosarcoma and undifferentiated uterine sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_provenance.
- NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_assertion evidence source_evidence_literature NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_provenance.
- NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_assertion SIO_000772 15581967 NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_provenance.
- NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_assertion wasDerivedFrom befree-20140225 NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_provenance.
- NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_assertion wasGeneratedBy ECO_0000203 NP814452.RA4QCeUKl9pdP4xAkPfvh3LjnKY-_nNgQV-eqAFW-O34E130_provenance.